Cal-Maine Foods (CALM) Q2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2026 earnings summary
7 Jan, 2026Executive summary
Q2 and first half of FY26 showed resilience despite lower egg prices, with a diversified business model and disciplined execution supporting momentum.
Specialty eggs and prepared foods now represent a significantly larger share of net sales, reflecting a strategic shift toward higher-value products and supporting earnings durability.
Prepared foods sales surged due to acquisitions and capacity expansion, despite short-term production declines from facility remodeling.
Net income for Q2 FY26 was $102.8M, down 53.1% year-over-year; first half net income was $302.1M, down 18.1%.
Financial highlights
Q2 net sales were $769.5M, down 19.4% year-over-year; first half net sales were $1.7B, down 2.8%.
Q2 gross profit was $207.4M (27.0% margin), down 41.8%; first half gross profit was $518.7M (30.7% margin), down 14.0%.
Q2 operating income was $123.9M (16.1% margin), down 55.5%; first half operating income was $373.1M (22.1% margin), down 19.8%.
Diluted EPS for Q2 was $2.13, down 52.3%; first half diluted EPS was $6.26, down 17.0%.
Net cash flow from operations in Q2 was $94.8M, down 22.8%; first half was $373.4M, up 55.5%.
Outlook and guidance
Management expects continued sales mix shift toward specialty eggs and prepared foods, with ongoing investments and acquisitions supporting double-digit growth and enhanced earnings durability.
Prepared foods capacity is expected to increase over 30% in the next 18–24 months through network optimization and joint ventures.
SG&A expenses are expected to remain elevated due to professional fees and promotional activity as specialty volumes grow.
Q3 prepared foods results are expected to show continued pullback due to expansion, with improvement anticipated from Q4 onward.
Specialty eggs projected to exceed 50% of total shell egg net sales over time.
Latest events from Cal-Maine Foods
- Strong growth, disciplined M&A, and specialty focus drive market leadership amid supply challenges.CALM
Stephens 26th Annual Investment Conference | NASH202413 Jan 2026 - Record Q1 with 17.4% sales growth, margin gains, and Echo Lake Foods boosting results.CALM
Q1 202623 Dec 2025 - Shareholders will vote on directors, auditor ratification, and officer exculpation amendment.CALM
Proxy Filing2 Dec 2025 - Proxy seeks approval for director elections, auditor ratification, and officer exculpation amendment.CALM
Proxy Filing2 Dec 2025 - Annual meeting to elect directors, ratify auditor, and highlight governance and compensation changes.CALM
Proxy Filing2 Dec 2025 - Lower sales offset by acquisitions and sustainability focus amid HPAI challenges.CALM
Proxy Filing2 Dec 2025 - Annual meeting to vote on directors, auditor, and officer exculpation amendment.CALM
Proxy Filing2 Dec 2025 - Record growth, acquisitions, and enhanced shareholder rights marked fiscal 2025.CALM
Proxy Filing2 Dec 2025 - Vote on director elections and auditor ratification at the October 2025 annual meeting.CALM
Proxy Filing2 Dec 2025